Background: Charcot neuro-osteoarthropathy (CNO) is a rare but devastating complication of diabetes associated with high rates of morbidity; yet, many nonfoot specialists are unaware of it, resulting in missed and delayed diagnosis. Clinical practice guidelines (CPGs) have proven useful in improving quality of care and standardizing practice in diabetes and diabetic foot care. However, little is known about the consistency in recommendations for identification and management of active CNO. Aim: The aim of this study is to review European national diabetes CPGs for the diagnosis and management of active CNO and to assess their methodological rigor and transparency. Methods: A systematic search was performed to identify diabetes national CPGs across Europe. Guidelines in any language were reviewed to explore whether they provided a definition for active CNO and recommendations for diagnosis, monitoring, and management. Methodological rigor and transparency were assessed using the Appraisal of Guidelines for Research and Evaluation (AGREE-II) tool, which comprises 23 key items organized within six domains with an overall guideline assessment score of ≥ 60% considered to be of adequate quality to recommend use. Each guideline was assessed by two reviewers, and inter-rater agreement (Kendall's W) was calculated for AGREE-II scores. Results: Seventeen CPGs met the inclusion criteria. Breadth of CNO content varied across guidelines (median (IQR) word count: 327; Q1 = 151; Q3 = 790), and 53% provided a definition for active CNO. Recommendations for diagnosis and monitoring were provided by 82% and 53%, respectively, with offloading being the most common management recommendation (88%). Four guidelines (24%) reached threshold for recommendation for use in clinical practice (≥ 60%) with the scope and purpose domain scoring highest (mean (SD): 67%, ± 23%). The remaining domains had average scores ranging between 19% and 53%. Inter-rater agreement was strong (W = 0.882; p < 0.001). Conclusions: European national CPGs for diabetes provide limited recommendations on active CNO. All guidelines showcased deficits in their methodology, suggesting that more rigorous methods should be employed for diabetes CPG development across Europe.

Bispebjerg Hospital University of Copenhagen Copenhagen Denmark

Department of Diabetes and Endocrinology University Hospitals of Derby and Burton NHS Foundation Trust Derby UK

Diabetes Centre Institute for Clinical and Experimental Medicine Prague Czech Republic

Diabetic Foot Clinic King's College Hospital NHS Foundation Trust London UK

Diabetic Foot Unit Complutense University of Madrid Madrid Spain

Division of Preventive Medicine and Education Medical University of Gdańsk Gdańsk Poland

Elsie Bertram Diabetes Centre Norfolk and Norwich University Hospitals NHS Foundation Trust Norwich UK

School of Medicine National and Kapodistrian University of Athens Athens Greece

School of Public Health University College Cork Cork Ireland

School of Sports Health and Exercise Science University of Portsmouth Portsmouth UK

Technical Orthopaedics and Diabetic Foot Surgery Klinik Dr Guth Hamburg Germany

Zobrazit více v PubMed

Rogers L. C., Frykberg R. G., Armstrong D. G., et al. The Charcot foot in diabetes. Diabetes Care . 2011;34(9):2123–2129. doi: 10.2337/dc11-0844. PubMed DOI PMC

Frykberg R. G., Belczyk R. Epidemiology of the Charcot foot. Clinics in Podiatric Medicine and Surgery . 2008;25(1):17–28. doi: 10.1016/j.cpm.2007.10.001. PubMed DOI

Sohn M. W., Stuck R. M., Pinzur M., Lee T. A., Budiman-Mak E. Lower-extremity amputation risk after Charcot arthropathy and diabetic foot ulcer. Diabetes Care . 2010;33(1):98–100. doi: 10.2337/DC09-1497. PubMed DOI PMC

Anichini R., Policardo L., Lombardo F. L., et al. Hospitalization for Charcot neuroarthropathy in diabetes: a population study in Italy. Diabetes Research and Clinical Practice . 2017;129:25–31. doi: 10.1016/J.DIABRES.2017.03.029. PubMed DOI

Gooday C., Hardeman W., Game F., Woodburn J., Poland F. A qualitative study to understand people’s experiences of living with Charcot neuroarthropathy. Diabetic Medicine . 2022;39(6, article e14784) doi: 10.1111/DME.14784. PubMed DOI PMC

Pakarinen T. K., Laine H. J., Mäenpää H., Mattila P., Lahtela J. Long-term outcome and quality of life in patients with Charcot foot. Foot and Ankle Surgery. . 2009;15(4):187–191. doi: 10.1016/J.FAS.2009.02.005. PubMed DOI

Raspovic K. M., Wukich D. K. Self-reported quality of life in patients with diabetes: a comparison of patients with and without charcot neuroarthropathy. Foot & Ankle International . 2014;35(3):195–200. doi: 10.1177/1071100713517097. PubMed DOI

Salini D., Harish K., Minnie P., et al. Prevalence of Charcot arthropathy in type 2 diabetes patients aged over 50 years with severe peripheral neuropathy: a retrospective study in a tertiary care south Indian hospital. Indian Journal of Endocrinology and Metabolism . 2018;22(1):107–111. doi: 10.4103/IJEM.IJEM_257_17. PubMed DOI PMC

Svendsen O. L., Rabe O. C., Winther-Jensen M., Allin K. H. How common is the rare Charcot foot in patients with diabetes? Diabetes Care . 2021;44(4):e62–e63. doi: 10.2337/DC20-2590. PubMed DOI

Wanzou J. P. V., Sekimpi P., Komagum J. O., Nakwagala F., Mwaka E. S. Charcot arthropathy of the diabetic foot in a sub-Saharan tertiary hospital: a cross-sectional study. Journal of Foot and Ankle Research . 2019;12(1) doi: 10.1186/S13047-019-0343-0. PubMed DOI PMC

Korst G. S., Ratliff H. T., Torian J., Jimoh R. O., Jupiter D. C. Delayed diagnosis of Charcot foot: a systematic review. The Journal of Foot and Ankle Surgery . 2022;61(5):1109–1113. doi: 10.1053/J.JFAS.2022.01.008. PubMed DOI

Safavi K. S., Torian J. S., Jimoh R. O., Jupiter D. A systematic review of Charcot neuroarthropathy misdiagnosis. Foot & Ankle Orthopaedics . 2022;7(1, article 2473011421S0042) doi: 10.1177/2473011421S00428. DOI

Armstrong D. G., Swerdlow M. A., Armstrong A. A., Conte M. S., Padula W. V., Bus S. A. Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer. Journal of Foot and Ankle Research . 2020;13(1) doi: 10.1186/s13047-020-00383-2. PubMed DOI PMC

Saluja S., Anderson S. G., Hambleton I., et al. Foot ulceration and its association with mortality in diabetes mellitus: a meta-analysis. Diabetic Medicine . 2020;37(2):211–218. doi: 10.1111/dme.14151. PubMed DOI

Ribu L., Birkeland K., Hanestad B. R., Moum T., Rustoen T. A longitudinal study of patients with diabetes and foot ulcers and their health-related quality of life: wound healing and quality-of-life changes. Journal of Diabetes and its Complications . 2008;22(6):400–407. doi: 10.1016/j.jdiacomp.2007.06.006. PubMed DOI

Sekhar M. S., Thomas R. R., Unnikrishnan M. K., Vijayanarayana K., Rodrigues G. S. Impact of diabetic foot ulcer on health-related quality of life: a cross-sectional study. Seminars in Vascular Surgery . 2015;28(3-4):165–171. doi: 10.1053/j.semvascsurg.2015.12.001. PubMed DOI

Diacogiorgis D., Perrin B. M., Kingsley M. I. C. Factors impacting the evidence-based assessment, diagnosis and management of acute Charcot neuroarthropathy: a systematic review. Journal of Foot and Ankle Research . 2021;14(1):1–12. doi: 10.1186/S13047-021-00469-5/TABLES/2. PubMed DOI PMC

Schmidt B. M., Wrobel J. S., Holmes C. M. Physician knowledge of a rare foot condition – influence of diabetic patient population on self-described knowledge and treatment. Clinical Diabetes and Endocrinology . 2017;3(1):1–3. doi: 10.1186/S40842-017-0041-4. PubMed DOI PMC

Guerra-Farfan E., Garcia-Sanchez Y., Jornet-Gibert M., Nuñez J. H., Balaguer-Castro M., Madden K. Clinical practice guidelines: the good, the bad, and the ugly. Injury . 2023;54(Supplement 3) doi: 10.1016/J.INJURY.2022.01.047. PubMed DOI

Panteli D., Legido-Quigley H., Reichebner C., Ollenschläger G., Schäfer C., Busse R. Clinical Practice Guidelines as a Quality Strategy. In: Busse R., Klazinga N., Panteli D., Quentin W., editors. Improving Healthcare Quality in Europe Characteristics, Effectiveness and Implementation of Different Strategies . Copenhagen (Denmark): European Observatory on Health Systems and Policies; 2019. PubMed

Sun Y., Ma L., Ji M., Wang Z. Evidence map of recommendations on diabetic foot ulcers care: a systematic review of 22 guidelines. Journal of Tissue Viability . 2022;31(2):294–301. doi: 10.1016/J.JTV.2022.03.001. PubMed DOI

Parker C. N., Van Netten J. J., Parker T. J., et al. Differences between national and international guidelines for the management of diabetic foot disease. Diabetes/Metabolism Research and Reviews . 2019;35(2, article e3101) doi: 10.1002/DMRR.3101. PubMed DOI

Barth J. H., Misra S., Aakre K. M., et al. Why are clinical practice guidelines not followed? Clinical Chemistry and Laboratory Medicine . 2016;54(7):1133–1139. doi: 10.1515/cclm-2015-0871. PubMed DOI

Brouwers M. C., Kho M. E., Browman G. P., et al. Analysis AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ . 2010;14(18):p. 182. doi: 10.1503/cmaj.090449. PubMed DOI PMC

Peters M., Godfrey C., McInerney P., Munn Z., Tricco A., Khalil H. Aromataris E., Munn Z., editors. Chapter 11: Scoping Reviews. JBI Manual for Evidence Synthesis . 2020. https://synthesismanual.jbi.global/

Peters M. D. J., Marnie C., Tricco A. C., et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evidence Synthesis . 2020;18(10):2119–2126. doi: 10.11124/JBIES-20-00167. PubMed DOI

Tricco A. C., Lillie E., Zarin W., et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Annals of Internal Medicine . 2018;169(7):467–473. doi: 10.7326/M18-0850. PubMed DOI

D-Foot International. D-foot international. 2022. https://d-foot.org/

Graham R., Mancher M., Wolman D. M., Greenfield S., Steinberg E. Clinical practice guidelines we can trust . National Academies Press; 2011. PubMed DOI

Popay J., Roberts H., Sowden A., et al. Guidance on the Conduct of Narrative Synthesis in Systematic Reviews a Product from the ESRC Methods Programme Peninsula Medical School . Universities of Exeter and Plymouth; 2006.

Jarl G., Hellstrand Tang U., Nordén E., Johannesson A., Rusaw D. F. Nordic clinical guidelines for orthotic treatment of osteoarthritis of the knee: a systematic review using the AGREE II instrument. Prosthetics and Orthotics International . 2019;43(5):556–563. doi: 10.1177/0309364619857854. PubMed DOI

Poitras I., Bielmann M., Mercier C., Bouyer L. J., Roy J. S. Criterion validity of wearable sensors in lower limb joint angle estimation: a systematic review. Annals of Physical and Rehabilitation Medicine . 2018;61:e441–e442. doi: 10.1016/j.rehab.2018.05.1027. DOI

Brosseau L., Rahman P., Toupin-April K., et al. A systematic critical appraisal for non-pharmacological management of osteoarthritis using the appraisal of guidelines research and evaluation II instrument. PLoS One . 2014;9(1) doi: 10.1371/JOURNAL.PONE.0082986. PubMed DOI PMC

Yan J., Min J., Zhou B. Diagnosis of pheochromocytoma: a clinical practice guideline appraisal using AGREE II instrument. Journal of Evaluation in Clinical Practice . 2013;19(4):626–632. doi: 10.1111/J.1365-2753.2012.01873.X. PubMed DOI

NICE. Clinical Guidelines. Diabetic Foot Problems Prevention and Management . 2019. https://www.nice.org.uk/guidance/ng19 .

Scottish Intercollegiate Guidelines Network. Management of Diabetes A National Clinical Guideline. 2017. http://www.sign.ac.uk/assets/

Peter-Riesch B., Czock A., Uçkay I. Swiss interdisciplinary guidance on good practices for acute and complicated diabetic foot syndromes. Swiss Medical Weekly . 2021;151(4546) doi: 10.4414/SMW.2021.W30045. PubMed DOI

Diabetic Foot Problems. Working group set up by the Finnish Medical Society Duodecim and the Finnish Cardiac Society . Helsinki: The Finnish Medical Society Duodecim; 2021. https://www.kaypahoito.fi .

Morbach S., Lobmann R., Eckhard M., et al. Diabetic Foot Syndrome. Experimental and Clinical Endocrinology & Diabetes . 2021;129(S01):S82–90. doi: 10.1055/a-1284-6412. PubMed DOI

Galstyan G. R., Tokmakova A. Y., Egorova D. N., et al. Clinical guidelines for diagnosis and treatment of diabetic foot syndrome. Wounds and Wound Infections. The prof. B.M. Kostyuchenok Journal . 2015;2(3):p. 63. doi: 10.17650/2408-9613-2015-2-3-63-83. DOI

Danish Society of Endocrinology. Diabetisk Fodsygdom . 2014. https://endocrinology.dk/nbv/diabetes-melitus/den-diabetiske-fod/

Recommended Procedure for Prevention, Diagnosis and Therapy of Diabetic Foot Syndrome . Czech Diabetological Society; 2016.

Federatie Medisch Specialisten. Diabetische Voet-Diagnostiek van Acute Charcot-Voet. 2021. https://richtlijnendatabase.nl/richtlijn/diabetische_voet/diagnostiek_en_behandeling_charcot/diagnostiek_van_acute_charcot-voet.html .

Martínez I. P., Villanueva E. M., Montoro M. I. R., Moh Al-lal Y., Espinosa M. T., Caparrós Cervante A. M. Guía Para La Prevención y Cuidado Del Pie Del Paciente Diabético . Instituto Nacional de Gestión Sanitaria; 2019. https://ingesa.sanidad.gob.es/Publicaciones-y-Documentaci-n/Publicaciones/Descargas-gratuitas/Gu-a-para-la-Prevenci-n-y-Cuidado-del-Pie-del-Paciente-Diab-tico.html .

Hellenic Diabetes Association. Guidelines for diabetes mellitus. 2023. http://www.ede.gr/katefthynt%EDries-odig%EDes-ede//

Approved Joint Comminsion on the quality of medical services Klinicheskiy Protokol Diagnostiki I Lecheniya Sindrom Diabeticheskoy Stopy . Ministry of Health Republic of Kazakhstan; 2019.

Araszkiewicz A., Bandurska-Stankiewicz E., Borys S., et al. 2021 Guidelines on the management of patients with diabetes. A position of Diabetes Poland. Clinical Diabetology . 2021;10(1):1–113.

Wochenschr W. K., Lechleitner M., Abrahamian H., et al. Leitlinien für die praxis Schlüsselwörter Diabetische Neuropathie Diabeti-scher Fuß. Wien Klin Wochenschr . 2019;131(S1):141–150. doi: 10.1007/s00508-019-1487-4. DOI

Bus S. A., Sacco I. C. N., Monteiro Soares M., et al. Guidelines on the prevention of foot ulcers in persons with diabetes IWGDF 2023 Update. 2023. http://www.iwgdfguidelines.org/ PubMed

Sohn M. W., Lee T. A., Stuck R. M., Frykberg R. G., Budiman-Mak E. Mortality risk of Charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone. Diabetes Care . 2009;32(5):816–821. doi: 10.2337/dc08-1695. PubMed DOI PMC

Van Netten J. J., Bus S. A., Apelqvist J., et al. Definitions and criteria for diabetes-related foot disease (IWGDF 2023 update) Diabetes/Metabolism Research and Reviews . 2023;40(3, article e3654) doi: 10.1002/dmrr.3654. PubMed DOI

Wukich D. K., Schaper N. C., Gooday C., et al. Guidelines on the diagnosis and treatment of active Charcot neuro-osteoarthropathy in persons with diabetes mellitus (IWGDF 2023) Diabetes/Metabolism Research and Reviews . 2024;40(3, article e3646) doi: 10.1002/DMRR.3646. PubMed DOI

Tan M. K. H., Goodall R., Hughes W., Langridge B., Shalhoub J., Davies A. H. A methodological assessment of diabetic foot syndrome clinical practice guidelines. European Journal of Vascular and Endovascular Surgery. . 2020;60(2):274–281. doi: 10.1016/j.ejvs.2020.04.028. PubMed DOI

Gagliardi A. R., Brouwers M. C. Do guidelines offer implementation advice to target users? A systematic review of guideline applicability. BMJ Open . 2015;5(2, article e007047) doi: 10.1136/BMJOPEN-2014-007047. PubMed DOI PMC

Eccles M. P., Grimshaw J. M., Shekelle P., Schünemann H. J., Woolf S. Developing clinical practice guidelines: target audiences, identifying topics for guidelines, guideline group composition and functioning and conflicts of interest. Implementation Science . 2012;7(1):1–8. doi: 10.1186/1748-5908-7-60/TABLES/2. PubMed DOI PMC

De Leo A., Bloxsome D., Bayes S. Approaches to clinical guideline development in healthcare: a scoping review and document analysis. BMC Health Services Research . 2023;23(1):1–13. doi: 10.1186/S12913-022-08975-3/FIGURES/3. PubMed DOI PMC

Balk E. M., Chung M., Chen M. L., Kong L., Chang W., Trikalinos T. A. Data extraction from machine-translated versus original language randomized trial reports: a comparative study. 2013. http://www.systematicreviewsjournal.com/content/2/1/97 . PubMed PMC

Health Service Executive (HSE) Office of the Nursing Services Director. National Wound Management Guidelines, 2018 . Dublin: Health Service Executive; 2018.

Chirilă V., Radulian G. 7. Piciorul diabetic Ghid de management al diabetului zaharat . Romanian Society of Diabetes, Nutrition and Metabolic Diseases; 2021.

Urbančič Rovan V., Lunder M., Ferjan S., Saletinger R., Lejko Zupanc T. 16. DIABETIČNA NOGA in Slovenske smernice za klinično obravnavo sladkorne bolezni tipa 2 . Diabetological Association of Slovenia; 2022.

Nationellt programområde endokrina sjukdomar. Personcentrerat och sammanhållet vårdförlopp Diabetes med hög risk för fotsår . Nationellt system för kunskapsstyrning hälso- och sjukvård; 2022.